Experiment: 7KWI

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.5 mM [U-15N] Autolysin repeat domain (R2ab) of Staphylococcus epidermidis, 20 mM sodium phosphate, 50 mM sodium chloride, 0.02 % w/v sodium azide	93% H2O/7% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 600
2	3D HNCACB	0.5 mM [U-15N];[U-13C] Autolysin repeat domain (R2ab) of Staphylococcus epidermidis, 20 mM sodium phosphate, 50 mM sodium chloride, 0.02 % w/v sodium azide	93% H2O/7% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 600
3	3D CBCA(CO)NH	0.5 mM [U-15N];[U-13C] Autolysin repeat domain (R2ab) of Staphylococcus epidermidis, 20 mM sodium phosphate, 50 mM sodium chloride, 0.02 % w/v sodium azide	93% H2O/7% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 600
4	3D HNCA	0.5 mM [U-15N];[U-13C] Autolysin repeat domain (R2ab) of Staphylococcus epidermidis, 20 mM sodium phosphate, 50 mM sodium chloride, 0.02 % w/v sodium azide	93% H2O/7% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 600
5	3D HN(CO)CA	0.5 mM [U-15N];[U-13C] Autolysin repeat domain (R2ab) of Staphylococcus epidermidis, 20 mM sodium phosphate, 50 mM sodium chloride, 0.02 % w/v sodium azide	93% H2O/7% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 600
6	3D HNCO	0.5 mM [U-15N];[U-13C] Autolysin repeat domain (R2ab) of Staphylococcus epidermidis, 20 mM sodium phosphate, 50 mM sodium chloride, 0.02 % w/v sodium azide	93% H2O/7% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 600
7	3D HBHA(CO)NH	0.5 mM [U-15N];[U-13C] Autolysin repeat domain (R2ab) of Staphylococcus epidermidis, 20 mM sodium phosphate, 50 mM sodium chloride, 0.02 % w/v sodium azide	93% H2O/7% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 600
8	3D H(CCCO)NH	0.5 mM [U-15N];[U-13C] Autolysin repeat domain (R2ab) of Staphylococcus epidermidis, 20 mM sodium phosphate, 50 mM sodium chloride, 0.02 % w/v sodium azide	93% H2O/7% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 600
9	3D (H)C(CCO)NH	0.5 mM [U-15N];[U-13C] Autolysin repeat domain (R2ab) of Staphylococcus epidermidis, 20 mM sodium phosphate, 50 mM sodium chloride, 0.02 % w/v sodium azide	93% H2O/7% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 600
10	3D 1H-15N NOESY	0.5 mM [U-15N];[U-13C] Autolysin repeat domain (R2ab) of Staphylococcus epidermidis, 20 mM sodium phosphate, 50 mM sodium chloride, 0.02 % w/v sodium azide	93% H2O/7% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III 600
11	2D 1H-13C HSQC aliphatic	0.5 mM [U-15N];[U-13C] Autolysin repeat domain (R2ab) of Staphylococcus epidermidis, 20 mM sodium phosphate, 50 mM sodium chloride, 0.02 % w/v sodium azide	100% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III HD 850
12	2D 1H-13C HSQC aromatic	0.5 mM [U-15N];[U-13C] Autolysin repeat domain (R2ab) of Staphylococcus epidermidis, 20 mM sodium phosphate, 50 mM sodium chloride, 0.02 % w/v sodium azide	100% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III HD 850
13	3D 1H-13C NOESY aliphatic	0.5 mM [U-15N];[U-13C] Autolysin repeat domain (R2ab) of Staphylococcus epidermidis, 20 mM sodium phosphate, 50 mM sodium chloride, 0.02 % w/v sodium azide	100% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III HD 850
14	3D 1H-13C NOESY aromatic	0.5 mM [U-15N];[U-13C] Autolysin repeat domain (R2ab) of Staphylococcus epidermidis, 20 mM sodium phosphate, 50 mM sodium chloride, 0.02 % w/v sodium azide	100% D2O	50 mM	6.5	1 atm	298	Bruker AVANCE III HD 850

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	600
2	Bruker	AVANCE III HD	850

NMR Refinement
Method	Details	Software
simulated annealing	cns-solve 1.3	CNS

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	chemical shift assignment	CARA	1.9v1	Keller and Wuthrich
3	structure calculation	CYANA	2.1	Guntert, Mumenthaler and Wuthrich
4	refinement	CNS	1.3	Brunger, Adams, Clore, Gros, Nilges and Read
5	peak picking	CARA	1.9v1	Keller and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.